345
Participants
Start Date
April 30, 2004
Primary Completion Date
February 28, 2005
Study Completion Date
February 28, 2005
Pramipexole
Winthrop Sleep Disorders Center, Mineola
The Arthritis Group, Philadelphia
Center For Sleep Medicine, Lafayette Hill
George Washington University Medical Faculty Associates, Washington D.C.
Center for Sleep and Wake Disorders, Chevy Chase
170 Thomas Johnson Dr, Suite 100, Frederick
1500 N. Bearegard St, #300, Alexandria
Eastern Virginia Medical School, Norfolk
Lynchburg Pulmonary Associates, Inc., Lynchburg
Raleigh Neurology Associates, Raleigh
932 Morreene Road #264, Durham
Wilmington Health Associates, Wilmington
Boehringer Ingelheim Investigational Site, Columbia
5671 Peachtree Dunwoody Road, Atlanta
Atlanta Pulmonary Group, LLC, Atlanta
Movement Disorders Clinic, Augusta
Sleepmed, Inc, Macon
Cleveland Clinic Florida- Department of Neurology, Weston
PAB Clinical Research, Brandon
Clinical Research Group of St Petersburg, St. Petersburg
Sleep Disorders Center, Jackson
Ohio Sleep Medicine Institute, Dublin
Metrohealth Medical Center, Cleveland
Attn: Dr. David Mayleben, Cincinnati
Henry Ford Hospital - Sleep Disorders and Research Center, Detroit
Hennepin County Medical Center, Minneapolis
Sleep Medicine Center, St Louis
Mid America NeuroScience Institute, Lenexa
Boehringer Ingelheim Investigational Site, Baton Rouge
Sleep Associates, Plano
Baylor College of Medicine, Houston
CNI Movement Disorders Center, Englewood
Adult CF Center, Denver
University of Colorado Health Sciences Center, Denver
Mayo Clinic - Scottsdale, Scottsdale
Pivotal Research Centers, Peoria
Lovelace Scientific Resources, Albuquerque
HealthQuest Clinical Trials Research, San Diego
Boehringer Ingelheim Investigational Site, Fountain Valley
Stanford Sleep Clinic, Stanford
Broward Research Group, Pembroke Pines
University of Iowa Health Care, Iowa City
Sleep Health Centers, Newton Center
Attn: Controller/Grants & Contracts Accounting, Oklahoma City
Lead Sponsor
Boehringer Ingelheim
INDUSTRY